Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.
Also called NCT05765175
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 380 participants
- Sponsor
- Varian, a Siemens Healthineers Company
- Registry
-
NCT05765175
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05765175. Randomized; no masking; primary purpose treatment. Start 2023-04-21 (actual); primary completion 2028-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
- Acronym
- RADIATE-VT
- Condition
- Tachycardia, Ventricular
- Intervention (Device)
- Varian Cardiac Radioablation (CRA)
- Intervention (Procedure)
- Catheter Ablation (CA)
- Lead sponsor
- Varian, a Siemens Healthineers Company
Record details
- Record id
cardio:ct-nct05765175- Content hash
d7344501d4492f7b2e3072b9d8f784e3e123eaabe021ffcd45f3d8cbd056fcd5